University of Texas Southwestern Medical Center: Carcinoma, Renal Cell trials

The registry lists 12 Carcinoma, Renal Cell studies with University of Texas Southwestern Medical Center as lead sponsor. 5 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 8No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney CancerRecruitingNCT06601296Phase 2
• PET/MR for Characterization of Renal Masses (RMs)RecruitingNCT06076538
• Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)RecruitingNCT05931393Phase 2
• Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor ThrombusRecruitingNCT05319015Phase 2
• An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or BiopsyRecruitingNCT04623502Not applicable
• Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell CarcinomaTerminatedNCT04831138Not applicableResults posted
• Mobile Intervention - Physical Activity in Cancer TreatmentTerminatedNCT03671304Not applicableResults posted
• SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer PatientsCompletedNCT03065179Phase 2Results posted
• Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT02781506Phase 2Results posted
• High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal CancerCompletedNCT01896271Phase 2Results posted
• SAbR For Oligo-Progressive Renal Cell Cancer.CompletedNCT03696277Phase 2
• Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCCActive, not recruitingNCT02473536Phase 1/2